Search research articles
Contact Us
Filters
Showing results (291-300 of 466) with videos related to
Page
of 47
Sort By:
Blood
|
October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2016
Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group
Gabor Kovacs, Sandra Robrecht, Anna Maria Fink, et al.
The Lancet. Oncology
|
October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Carmen D Herling, Kevin R Coombes, Axel Benner, et al.
Blood
|
May 13, 2010
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies
Inga Nagel, Monika Szczepanowski, José I Martín-Subero, et al.
Cancer Discovery
|
December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
Christopher C Oakes, Rainer Claus, Lei Gu, et al.
Blood Advances
|
June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia
Jialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.
Blood
|
April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia
Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Science Translational Medicine
|
January 17, 2020
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance
Eugene Park, Jingyu Chen, Andrew Moore, et al.
Blood
|
May 27, 2016
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy
Carmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, et al.
Science Immunology
|
July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Franziska Haderk, Ralph Schulz, Murat Iskar, et al.
Page
of 47
Search research articles
Search
Showing results (291-300 of 466) with videos related to
Sort By:
Page
of 47
Blood
|
October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2016
Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group
Gabor Kovacs, Sandra Robrecht, Anna Maria Fink, et al.
The Lancet. Oncology
|
October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Carmen D Herling, Kevin R Coombes, Axel Benner, et al.
Blood
|
May 13, 2010
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies
Inga Nagel, Monika Szczepanowski, José I Martín-Subero, et al.
Cancer Discovery
|
December 21, 2013
Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
Christopher C Oakes, Rainer Claus, Lei Gu, et al.
Blood Advances
|
June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia
Jialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.
Blood
|
April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia
Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Science Translational Medicine
|
January 17, 2020
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance
Eugene Park, Jingyu Chen, Andrew Moore, et al.
Blood
|
May 27, 2016
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy
Carmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, et al.
Science Immunology
|
July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Franziska Haderk, Ralph Schulz, Murat Iskar, et al.
Page
of 47